Mode
Text Size
Log in / Sign up

Exercise programs improve muscle mass and physical performance indicators in patients with liver cirrhosisExercise improves muscle strength in cirrhosis patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider exercise programs to improve muscle mass and physical performance in patients with liver cirrhosis.

This meta-analysis synthesized data from 16 studies involving 942 patients with liver cirrhosis and sarcopenia to evaluate the efficacy of exercise programs, including both aerobic and resistance components. The analysis indicates that exercise interventions lead to significant improvements in several physical performance and muscle mass metrics. Specifically, mean differences (MD) were observed for 6-min walk distance (MD = 54.35; 95% CI 34.56 to 74.14), thigh circumference (MD = 1.83; 95% CI 0.92 to 3.38), knee extensor strength (MD = 8.06; 95% CI 2.59 to 13.53), and thigh muscle thickness (MD = 0.09; 95% CI 0.05 to 0.14). Additionally, CLDQ scores improved by a mean difference of 0.75.

Conversely, the meta-analysis found no significant changes in MELD scores or handgrip strength. The authors note that while both aerobic and resistance exercises appear to improve physical activity levels, further research is required to determine the specific impact of different exercise types.

Clinically, these findings suggest that structured exercise programs may be a viable intervention for improving muscle mass and functional capacity in patients with cirrhosis. However, practitioners should note the lack of differentiation between aerobic and resistance modalities in the current data.

How this fits prior evidence

This meta-analysis addresses a gap in managing sarcopenia by providing evidence on physical interventions. It builds upon prior findings that different exercise modalities mitigate systemic and local inflammation in older adults with sarcopenia. While previous evidence established the role of exercise in inflammatory pathways, this study specifically quantifies improvements in muscle thickness and walking distance for patients with liver cirrhosis.

A new analysis of 16 studies involving 942 people with liver cirrhosis and sarcopenia (muscle loss) found that exercise programs can improve muscle strength and physical function. The meta-analysis looked at aerobic and resistance exercises and measured outcomes like walking distance, thigh circumference, and knee extensor strength.

Participants who exercised showed significant improvements in the 6-minute walk distance (an average increase of 54 meters), thigh circumference, knee extensor strength, thigh muscle thickness, and quality of life scores. Gait speed also improved. However, handgrip strength and liver disease severity scores (MELD) did not change significantly.

The study did not report any safety concerns or adverse events. The authors note that more research is needed to determine which type of exercise (aerobic vs. resistance) is most effective.

For people with cirrhosis and muscle loss, this analysis suggests that exercise may help improve muscle mass and physical performance. Talk to your doctor before starting any new exercise program.

What this means for you:
Exercise may improve muscle strength and walking ability in people with cirrhosis and muscle loss.

Common questions

What is sarcopenia in liver cirrhosis?

Sarcopenia is the loss of muscle mass and strength that often occurs in people with chronic liver disease like cirrhosis. It can affect physical function and quality of life.

What types of exercise were studied?

The analysis included aerobic exercise and resistance exercise programs. Both types appeared to help improve physical activity levels, but more research is needed to compare them directly.

Did exercise improve handgrip strength?

No, the analysis found no significant change in handgrip strength after exercise. However, other measures like thigh circumference and walking distance did improve.

Is exercise safe for people with cirrhosis?

The study did not report any adverse events or safety concerns. However, it is important to talk to your doctor before starting an exercise program, especially if you have liver disease.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundSarcopenia and frailty are common issues faced by individuals suffering from liver cirrhosis. These ailments greatly diminish life quality and increase the likelihood of death. Engaging in physical activity is a popular method to improve sarcopenia. Consequently, this systematic review and meta-analysis seeks to assess the effectiveness of exercise programs for addressing sarcopenia in those with liver cirrhosis.PurposeThis study evaluated the efficacy of exercise interventions on sarcopenia in patients with liver cirrhosis through a meta-analysis of randomized controlled trials (RCTs).MethodsA comprehensive literature search was conducted across five databases: PubMed, Embase, CINAHL, CNKI, and the Cochrane Library, up to March 2026. Manually search for references in review articles that may meet the requirements. Two researchers independently carried out the literature search and review, data extraction and assessment of risk of bias. The analysis of results includes 6-min walk distance (6MWD), thigh circumference, knee extensor strength, gait speed, thigh muscle thickness, Chronic Liver Disease Questionnaire (CLDQ), Model for End-Stage Liver Disease (MELD) scores and handgrip strength. Statistical analyses were performed using Rev Man 5.3 and STATA 14.0.ResultsThis meta-analysis included 16 studies involving a total of 942 patients. The results demonstrated that exercise significantly enhanced various physical and clinical metrics in patients suffering from liver cirrhosis and sarcopenia. Notably, significant improvements were recorded in the 6MWD (MD = 54.35, 95% CI = 34.56–74.14, P < 0.001), thigh circumference (MD = 1.83, 95% CI = 0.92–3.38, P = 0.020), knee extensor strength (MD = 8.06, 95% CI = 2.59–13.53, P = 0.004), thigh muscle thickness (MD = 0.09, 95% CI = 0.05–0.14, P < 0.001), and scores on the CLDQ (MD = 0.75, 95% CI = 0.51–0.99, P < 0.001). Additionally, gait speed exhibited a significant increase (MD = 1.17, 95% CI = 0.09–2.26, P = 0.030). However, no significant changes were observed in grip strength, or MELD scores. Subgroup analysis indicates that aerobic exercise, or Resistance exercise, appear to improve physical activity levels in patients with cirrhosis.ConclusionExercise may improve selected indicators of muscle mass and physical performance in patients with cirrhosis. Exercise improves thigh muscle thickness, thigh circumference, and knee extension strength in patients with sarcopenia and cirrhosis, while also enhancing their physical activity capacity and quality of life. In terms of exercise type, both aerobic and resistance training appear to improve physical activity levels in patients with cirrhosis. However, further research is needed to confirm this.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD420261326379.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.